On Watchlist: CombiMatrix Corp (NASDAQ:CBMX); Liquidmetal Technologies Inc (OTCBB:LQMT) And mCig Inc (OTCBB:MCIG)

Boston, MA 03/18/2014 (wallstreetpr) – CombiMatrix Corp (NASDAQ:CBMX), which is dedicated in DNA-based testing with emphasis on developmental disorders and cancer and is a molecular diagnostics company, made a press release last week that it has been chosen by American Pathology Partners (AP2), to partner in its chromosomal microarray analysis (CMA) testing. The partnership between […]